Peptide record

TPDB10219

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10219
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 23-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLRFIGSVIHGIGHLVHHIGVAL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C119H186N34O25
NDCEQKMPTWY
GHI
2493.00
11.05
5
0
13
+1
-0.92
1.291
160.87
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
1
Residue Composition
number
1
A
1
R
0
N
0
D
0
C
0
E
0
Q
4
G
4
H
4
I
3
L
0
K
0
M
2
F
0
P
1
S
0
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 4 H: 4 I: 4 L: 3 K: 0 M: 0 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 3
Chemical Descriptors
23 reviewed residue count
C119H186N34O25 sequence-only estimate (linear, free termini)
2493.00 sequence-only estimate (linear, free termini)
11.05 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-0.92 sequence-only estimate (linear, free termini)
1.291 sequence-only estimate (linear, free termini)
Evidence Records 8 records
Evidence 1 Activity

Activity

Hemolysis
[Ref.12005415]has potent hemolytic activity

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
J Pept Res. 2001 Dec 58(6):445-456.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 2 Activity

Activity

75% Hemolysis
Toxicity
40 µg/mL
Hemolytic Cytotoxic
75% Hemolysis | 40 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Clavaspirin, an antibacterial and haemolytic peptide from Styela clava. | J Pept Res | 2001
Evidence 3 Activity

Activity

60% Hemolysis
Toxicity
40 µg/mL
Hemolytic Cytotoxic
60% Hemolysis | 40 | µg/mL | target cell: Bovine erythrocytes

Target

Bovine erythrocytes

Source & Reference

NA
DBAASP
Clavaspirin, an antibacterial and haemolytic peptide from Styela clava. | J Pept Res | 2001
Evidence 4 Activity

Activity

10% Hemolysis
Toxicity
37 µM
Hemolytic Cytotoxic
10% Hemolysis | 37 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
New antimicrobial peptide kills drug-resistant pathogens without detectable resistance | Oncotarget | 2018
Evidence 5 Activity

Activity

50% Hemolysis
Toxicity
64 µM
Hemolytic Cytotoxic
50% Hemolysis | 64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
New antimicrobial peptide kills drug-resistant pathogens without detectable resistance | Oncotarget | 2018
Evidence 6 Activity

Activity

EC50
Toxicity
247 µM
Cytotoxic
EC50 | 247 | µM | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
New antimicrobial peptide kills drug-resistant pathogens without detectable resistance | Oncotarget | 2018
Evidence 7 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.12005415]has potent hemolytic activity

Target

erythrocytes

Source & Reference

NA
DRAMP
J Pept Res. 2001 Dec 58(6):445-456.
Evidence 8 Hemolysis

Activity

[Ref.12005415]has potent hemolytic activity
Hemolysis

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
J Pept Res. 2001 Dec 58(6):445-456.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.